The anti-inflammatory properties of, mesenchymal stem cells in epilepsy: possible treatments and future perspectives
The FDA has authorized HyQvia (immune globulin infusion 10% with recombinant human hyaluronidase) as a maintenance treatment to prevent the relapse of neuromuscular disability and impairment in adult patients with CIDP
In recent years, increasing evidence has suggested that REV, as an inducer of ferroptosis can inhibit the proliferation of various tumors, such as colorectal cancer (114, 115), acute myeloid leukemia (162), lung squamous cell carcinoma (116), and canine mammary tumors (163)
P.NordbergM
Risk factors for these health problems include long-term use of anorectics, taking higher than the recommended dosage, and combining more than one anorectic agent
Science , 378 (6618), 422-428